2014
DOI: 10.1001/jamaneurol.2013.4677
|View full text |Cite
|
Sign up to set email alerts
|

Mutations inGNAL

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(21 citation statements)
references
References 14 publications
0
21
0
Order By: Relevance
“…In type I ACS, a single mutant allele is sufficient to cause the disease because of the dominant-negative action of Gα i3 variants, whereas in other diseases a single G protein mutant allele causes haploinsufficiency. For example, primary torsion dystonia, craniocervical dystonia or Albright’s Hereditary Osteodystrophy (AHO) can be caused by non-sense or missense mutations that lead to no protein or severe protein structural defects (5, 9, 10). Nougaret night blindness is caused by a missense mutation in Gαt, but it has been unequivocally established that the disease arises from a loss of function not accompanied by any dominant-negative function (7, 8).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In type I ACS, a single mutant allele is sufficient to cause the disease because of the dominant-negative action of Gα i3 variants, whereas in other diseases a single G protein mutant allele causes haploinsufficiency. For example, primary torsion dystonia, craniocervical dystonia or Albright’s Hereditary Osteodystrophy (AHO) can be caused by non-sense or missense mutations that lead to no protein or severe protein structural defects (5, 9, 10). Nougaret night blindness is caused by a missense mutation in Gαt, but it has been unequivocally established that the disease arises from a loss of function not accompanied by any dominant-negative function (7, 8).…”
Section: Discussionmentioning
confidence: 99%
“…The majority of G protein-associated mutations have been identified in genes encoding Gα subunits (5, 6) and are broadly classified as loss-of-function or gain-of-function mutations. Loss-of-function mutations in various Gα proteins are associated with the congenital diseases Albright’s Hereditary Osteodystrophy (Gα s ), Nougaret night blindness (Gα t ) and two types of dystonia (Gα olf ) (5, 710). On the other hand, gain-of-function mutations are somatic and exert a dominant effect by rendering the Gα subunit constitutively active.…”
Section: Introductionmentioning
confidence: 99%
“…The degraded action selection which underpins these involuntary movements have long been thought to be the consequence of dysfunction within the basal ganglia, based on clinical observation (Berardelli et al, 1998;Bhatia & Marsden, 1994), neuroimaging (Colosimo et al, 2005;Draganski et al, 2009;Naumann et al, 1998;Zoons, Booij, Nederveen, Dijk, & Tijssen, 2011), and its secondary association with "extra-pyramidal" disorders (Burke et al, 1982;Louis, Lee, Quinn, & Marder, 1999;Rivest, Quinn, & Marsden, 1990). The recent identification of families with novel mutations in genes which encode proteins richly expressed within the striatum implicated in dopaminergic signal transduction, e.g., GNAL (Kumar et al, 2014), and ANO3 (Charlesworth et al, 2012) has reignited interest in "old ideas" about dopaminergic dysfunction being a common pathophysiological hallmark (Goodchild, Grundmann, & Pisani, 2013). For patients with cervical dystonia, detailed molecular and neurophysiological understanding of the nature of this derangement in signaling is crucial for the development of new treatments.…”
Section: Introductionmentioning
confidence: 99%
“…A C-terminal fragment of the G protein receptor kinase 3 (GRK3ct) that binds to free Gβγ dimers fused to a luciferase serves as a BRET donor. Originally developed using Renilla luciferase as a BRET donor [4], the assay has been improved by substitution of the engineered NanoLuc from Oplophorus [2, 5]. This sensor is coexpressed with an unlabeled Gα subunit and a Gβγ dimer labeled with a BRET acceptor, generally the fluorescent protein venus (assembled by bimolecular fluorescence complementation; BiFC) [6].…”
Section: Introductionmentioning
confidence: 99%